{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T21:26:24Z","timestamp":1789334784627,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,6,14]],"date-time":"2013-06-14T00:00:00Z","timestamp":1371168000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Cervical cancer is the third most common cancer among women worldwide, and in Nigeria it is the second most common female cancer. Cervical cancer is an AIDS-defining cancer; however, HIV only marginally increases the risk of cervical pre-cancer and cancer. In this study, we examine the risk factors for cervical pre-cancer and cancer among HIV-positive women screened for cervical cancer at two medical institutions in Abuja, Nigeria.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A total of 2,501 HIV-positive women participating in the cervical cancer screen-and-treat program in Abuja, Nigeria consented to this study and provided socio-demographic and clinical information. Log-binomial models were used to calculate relative risk (RR) and 95% confidence intervals (95%CI) for the risk factors of cervical pre-cancer and cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>There was a 6% prevalence of cervical pre-cancer and cancer in the study population of HIV-positive women. The risk of screening positivity or invasive cancer diagnosis reduced with increasing age, with women aged 40 years and older having the lowest risk (RR=0.4; 95%CI=0.2\u20130.7). Women with a CD4 count of 650 per mm<jats:sup>3<\/jats:sup> or more also had lower risk of screening positivity or invasive cancer diagnosis (RR=0.3, 95%CI=0.2\u20130.6). Other factors such as having had 5 or more abortions (RR=1.8, 95%CI=1.0\u20133.6) and the presence of other vaginal wall abnormalities (RR=1.9, 95%CI=1.3\u20132.8) were associated with screening positivity or invasive cancer diagnosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The prevalence of screening positive lesions or cervical cancer was lower than most previous reports from Africa. HIV-positive Nigerian women were at a marginally increased risk of cervical pre-cancer and cancer. These findings highlight the need for more epidemiological studies of cervical cancer and pre-cancerous lesions among HIV-positive women in Africa and an improved understanding of incidence and risk factors.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2458-13-582","type":"journal-article","created":{"date-parts":[[2013,6,14]],"date-time":"2013-06-14T17:27:18Z","timestamp":1371230838000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Cervical cancer risk factors among HIV-infected Nigerian women"],"prefix":"10.1186","volume":"13","author":[{"given":"Uzoma","family":"Ononogbu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Almujtaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Modibbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishak","family":"Lawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Offiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olayinka","family":"Olaniyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Dakum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Spiegelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Blattner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement","family":"Adebamowo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,6,14]]},"reference":[{"key":"5630_CR1","volume-title":"GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10 [Internet]","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10 [Internet]. 2010, Lyon, France: International Agency for Research on Cancer"},{"issue":"1","key":"5630_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1750-9378-6-16","volume":"6","author":"SM Mbulaiteye","year":"2011","unstructured":"Mbulaiteye SM, Bhatia K, Adebamowo C, Sasco AJ: HIV and cancer in Africa: mutual collaboration between HIV and cancer programs may provide timely research and public health data. Infectious Agents and Cancer. 2011, 6 (1): 16-10.1186\/1750-9378-6-16.","journal-title":"Infectious Agents and Cancer"},{"issue":"5","key":"5630_CR3","doi-asserted-by":"publisher","first-page":"e271","DOI":"10.1016\/j.canep.2012.04.007","volume":"36","author":"E Jedy-Agba","year":"2012","unstructured":"Jedy-Agba E, Curado MP, Ogunbiyi O, Oga E, Fabowale T, Igbinoba F, Osubor G, Otu T, Kumai H, Koechlin A: Cancer incidence in Nigeria: A report from population-based cancer registries. Cancer Epidemiology. 2012, 36 (5): e271-e278. 10.1016\/j.canep.2012.04.007.","journal-title":"Cancer Epidemiology"},{"issue":"1","key":"5630_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/sj.bjc.6600688","volume":"88","author":"GM Clifford","year":"2003","unstructured":"Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S: Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer. 2003, 88 (1): 63-73. 10.1038\/sj.bjc.6600688.","journal-title":"Br J Cancer"},{"issue":"4","key":"5630_CR5","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/ijc.26470","volume":"131","author":"HD Vuyst","year":"2012","unstructured":"Vuyst HD, Ndirangu G, Moodley M, Tenet V, Estambale B, Meijer CJ, Snijders PJ, Clifford G, Franceschi S: Prevalence of human papillomavirus in women with invasive cervical carcinoma by HIV status in Kenya and South Africa. International journal of cancer Journal international du cancer. 2012, 131 (4): 949-955. 10.1002\/ijc.26470.","journal-title":"International journal of cancer Journal international du cancer"},{"issue":"5","key":"5630_CR6","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/jnci\/djj067","volume":"98","author":"X Castellsague","year":"2006","unstructured":"Castellsague X, Diaz M, de Sanjose S, Munoz N, Herrero R, Franceschi S, Peeling RW, Ashley R, Smith JS, Snijders PJ, et al: Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst. 2006, 98 (5): 303-315. 10.1093\/jnci\/djj067.","journal-title":"J Natl Cancer Inst"},{"issue":"31","key":"5630_CR7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/oxfordjournals.jncimonographs.a003477","volume":"31","author":"X Castellsague","year":"2003","unstructured":"Castellsague X, Munoz N: Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking. Journal of the National Cancer Institute Monographs. 2003, 31 (31): 20-28.","journal-title":"Journal of the National Cancer Institute Monographs"},{"issue":"1","key":"5630_CR8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1093\/carcin\/bgp263","volume":"31","author":"MJ Thun","year":"2010","unstructured":"Thun MJ, DeLancey JO, Center MM, Jemal A, Ward EM: The global burden of cancer: priorities for prevention. Carcinogenesis. 2010, 31 (1): 100-110. 10.1093\/carcin\/bgp263.","journal-title":"Carcinogenesis"},{"issue":"18","key":"5630_CR9","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1093\/jnci\/92.18.1500","volume":"92","author":"M Frisch","year":"2000","unstructured":"Frisch M, Biggar RJ, Goedert JJ: Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst. 2000, 92 (18): 1500-1510. 10.1093\/jnci\/92.18.1500.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"5630_CR10","doi-asserted-by":"publisher","first-page":"625","DOI":"10.2217\/hiv.10.58","volume":"4","author":"G Parham","year":"2010","unstructured":"Parham G: Cervical cancer prevention in HIV-infected women in resource-limited settings. HIV Therapy. 2010, 4 (6): 625-628. 10.2217\/hiv.10.58.","journal-title":"HIV Therapy"},{"issue":"6","key":"5630_CR11","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/CEJ.0b013e3282f75ea1","volume":"17","author":"H De Vuyst","year":"2008","unstructured":"De Vuyst H, Lillo F, Broutet N, Smith JS: HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy. Eur J Cancer Prev. 2008, 17 (6): 545-554. 10.1097\/CEJ.0b013e3282f75ea1.","journal-title":"Eur J Cancer Prev"},{"issue":"8","key":"5630_CR12","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1001\/jama.283.8.1031","volume":"283","author":"TV Ellerbrock","year":"2000","unstructured":"Ellerbrock TV, Chiasson MA, Bush TJ, Sun XW, Sawo D, Brudney K, Wright TC: Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA. 2000, 283 (8): 1031-1037. 10.1001\/jama.283.8.1031.","journal-title":"JAMA"},{"issue":"6","key":"5630_CR13","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1086\/323081","volume":"184","author":"L Ahdieh","year":"2001","unstructured":"Ahdieh L, Klein RS, Burk R, Cu-Uvin S, Schuman P, Duerr A, Safaeian M, Astemborski J, Daniel R, Shah K: Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis. 2001, 184 (6): 682-690. 10.1086\/323081.","journal-title":"J Infect Dis"},{"issue":"15","key":"5630_CR14","first-page":"1823","volume":"92","author":"HIV Ic","year":"2000","unstructured":"Ic HIV, Coutinho RA: Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst. 2000, 92 (15): 1823-1830.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"5630_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/COH.0b013e328319bcbe","volume":"4","author":"I Heard","year":"2009","unstructured":"Heard I: Prevention of cervical cancer in women with HIV. Curr Opin HIV AIDS. 2009, 4 (1): 68-73. 10.1097\/COH.0b013e328319bcbe.","journal-title":"Curr Opin HIV AIDS"},{"issue":"5","key":"5630_CR16","doi-asserted-by":"publisher","first-page":"e1001032","DOI":"10.1371\/journal.pmed.1001032","volume":"8","author":"MH Mwanahamuntu","year":"2011","unstructured":"Mwanahamuntu MH, Sahasrabuddhe VV, Kapambwe S, Pfaendler KS, Chibwesha C, Mkumba G, Mudenda V, Hicks ML, Vermund SH, Stringer JS, et al: Advancing cervical cancer prevention initiatives in resource-constrained settings: insights from the Cervical Cancer Prevention Program in Zambia. PLoS Med. 2011, 8 (5): e1001032-10.1371\/journal.pmed.1001032.","journal-title":"PLoS Med"},{"issue":"12","key":"5630_CR17","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1093\/jnci\/djm010","volume":"99","author":"RJ Biggar","year":"2007","unstructured":"Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA: AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst. 2007, 99 (12): 962-972. 10.1093\/jnci\/djm010.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"5630_CR18","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/jnci\/dji072","volume":"97","author":"GM Clifford","year":"2005","unstructured":"Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, Rapiti E, Levi F, Jundt G, Fisch T: Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005, 97 (6): 425-432. 10.1093\/jnci\/dji072.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"5630_CR19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.vaccine.2006.05.121","volume":"24","author":"L Denny","year":"2006","unstructured":"Denny L, Quinn M, Sankaranarayanan R: Chapter 8: Screening for cervical cancer in developing countries. Vaccine. 2006, 24 (3): 71-77.","journal-title":"Vaccine"},{"issue":"5","key":"5630_CR20","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.canep.2012.05.010","volume":"36","author":"EE Jedy-Agba","year":"2012","unstructured":"Jedy-Agba EE, Curado MP, Oga E, Samaila MO, Ezeome ER, Obiorah C, Erinomo OO, Ekanem IA, Uka C, Mayun A: The role of hospital-based cancer registries in low and middle income countries-The Nigerian Case Study. Cancer Epidemiol. 2012, 36 (5): 430-435. 10.1016\/j.canep.2012.05.010.","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"5630_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ijgo.2010.10.012","volume":"113","author":"C Sauvaget","year":"2011","unstructured":"Sauvaget C, Fayette JM, Muwonge R, Wesley R, Sankaranarayanan R: Accuracy of visual inspection with acetic acid for cervical cancer screening. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2011, 113 (1): 14-24. 10.1016\/j.ijgo.2010.10.012.","journal-title":"International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics"},{"issue":"1","key":"5630_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1158\/1940-6207.CAPR-11-0540","volume":"5","author":"VV Sahasrabuddhe","year":"2012","unstructured":"Sahasrabuddhe VV, Parham GP, Mwanahamuntu MH, Vermund SH: Cervical cancer prevention in low- and middle-income countries: feasible, affordable, essential. Cancer Prev Res (Phila). 2012, 5 (1): 11-17. 10.1158\/1940-6207.CAPR-11-0540.","journal-title":"Cancer Prev Res (Phila)"},{"key":"5630_CR23","first-page":"59","volume-title":"Cervix Cancer Screening. Volume 10","author":"IARC","year":"2005","unstructured":"IARC: Screening Tests. Cervix Cancer Screening. Volume 10. 2005, Lyon, France: IARC, 59-109."},{"key":"5630_CR24","volume-title":"A practical manual on visual screening for cervical neoplasia","author":"R Sankaranarayanan","year":"2003","unstructured":"Sankaranarayanan R, Wesley RS: A practical manual on visual screening for cervical neoplasia. 2003, Lyon, France: IARC Press, [IARC Technical Publication No. 41]"},{"issue":"3","key":"5630_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/aje\/kwi188","volume":"162","author":"D Spiegelman","year":"2005","unstructured":"Spiegelman D, Hertzmark E: Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol. 2005, 162 (3): 199-200. 10.1093\/aje\/kwi188.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"5630_CR26","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/oxfordjournals.aje.a114212","volume":"123","author":"S Wacholder","year":"1986","unstructured":"Wacholder S: Binomial regression in GLIM: estimating risk ratios and risk differences. Am J Epidemiol. 1986, 123 (1): 174-184.","journal-title":"Am J Epidemiol"},{"issue":"11","key":"5630_CR27","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/oxfordjournals.aje.a116813","volume":"138","author":"G Maldonado","year":"1993","unstructured":"Maldonado G, Greenland S: Simulation study of confounder-selection strategies. Am J Epidemiol. 1993, 138 (11): 923-936.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"5630_CR28","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/sim.4780080504","volume":"8","author":"S Durrleman","year":"2006","unstructured":"Durrleman S, Simon R: Flexible regression models with cubic splines. Stat Med. 2006, 8 (5): 551-561.","journal-title":"Stat Med"},{"issue":"20","key":"5630_CR29","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.1002\/sim.2848","volume":"26","author":"US Govindarajulu","year":"2007","unstructured":"Govindarajulu US, Spiegelman D, Thurston SW, Ganguli B, Eisen EA: Comparing smoothing techniques in Cox models for exposure\u2013response relationships. Stat Med. 2007, 26 (20): 3735-3752. 10.1002\/sim.2848.","journal-title":"Stat Med"},{"key":"5630_CR30","volume-title":"Interim WHO clinical staging of HIV\/AIDS and HIV\/AIDS case definitions for surveillance: African region","author":"World Health Organization","year":"2005","unstructured":"World Health Organization: Interim WHO clinical staging of HIV\/AIDS and HIV\/AIDS case definitions for surveillance: African region. 2005, Geneva, Switzerland: World Health Organization"},{"issue":"2","key":"5630_CR31","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1136\/sti.75.2.103","volume":"75","author":"V Leroy","year":"1999","unstructured":"Leroy V, Ladner J, De Clercq A, Meheus A, Nyiraziraje M, Karita E, Dabis F: Cervical dysplasia and HIV type 1 infection in African pregnant women: a cross sectional study, Kigali, Rwanda. The Pregnancy and HIV Study Group (EGE). Sex Transm Infect. 1999, 75 (2): 103-106. 10.1136\/sti.75.2.103.","journal-title":"Sex Transm Infect"},{"key":"5630_CR32","doi-asserted-by":"publisher","first-page":"953743","DOI":"10.1155\/2012\/953743","volume":"2012","author":"P Memiah","year":"2012","unstructured":"Memiah P, Mbuthia W, Kiiru G, Agbor S, Odhiambo F, Ojoo S, Biadgilign S: Prevalence and Risk Factors Associated with Precancerous Cervical Cancer Lesions among HIV-Infected Women in Resource-Limited Settings. AIDS research and treatment. 2012, 2012: 953743-","journal-title":"AIDS research and treatment"},{"issue":"1","key":"5630_CR33","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/1471-2407-9-275","volume":"9","author":"J Moodley","year":"2009","unstructured":"Moodley J, Constant D, Hoffman M, Salimo A, Allan B: Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study. BMC Cancer. 2009, 9 (1): 275-10.1186\/1471-2407-9-275.","journal-title":"BMC Cancer"},{"issue":"6","key":"5630_CR34","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/jmv.20817","volume":"79","author":"DB Blossom","year":"2007","unstructured":"Blossom DB, Beigi RH, Farrell JJ, Mackay W, Qadadri B, Brown DR, Rwambuya S, Walker CJ, Kambugu FS, Abdul-Karim FW: Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women. J Med Virol. 2007, 79 (6): 758-765. 10.1002\/jmv.20817.","journal-title":"J Med Virol"},{"issue":"3","key":"5630_CR35","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.ygyno.2006.06.015","volume":"103","author":"GP Parham","year":"2006","unstructured":"Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Shepherd BE, Hicks ML, Stringer EM, Vermund SH: Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Gynecol Oncol. 2006, 103 (3): 1017-1022. 10.1016\/j.ygyno.2006.06.015.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"5630_CR36","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1086\/376996","volume":"188","author":"SE Hawes","year":"2003","unstructured":"Hawes SE, Critchlow CW, Niang MAF, Diouf MB, Diop A, Toure P, Kasse AA, Dembele B, Sow PS, Coll-Seck AM: Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections. J Infect Dis. 2003, 188 (4): 555-563. 10.1086\/376996.","journal-title":"J Infect Dis"},{"issue":"1","key":"5630_CR37","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/sj.bjc.6605140","volume":"101","author":"N Keita","year":"2009","unstructured":"Keita N, Clifford GM, Koulibaly M, Douno K, Kabba I, Haba M, Sylla BS, Van Kemenade FJ, Snijders PJF, Meijer C: HPV infection in women with and without cervical cancer in Conakry, Guinea. Br J Cancer. 2009, 101 (1): 202-208. 10.1038\/sj.bjc.6605140.","journal-title":"Br J Cancer"},{"issue":"1","key":"5630_CR38","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4103\/1742-6413.54916","volume":"6","author":"S Okonda","year":"2009","unstructured":"Okonda S, Wright C, Michelow P: The status of cervical cytology in Swaziland, Southern Africa: a descriptive study. Cytojournal. 2009, 6 (1): 14-10.4103\/1742-6413.54916.","journal-title":"Cytojournal"},{"issue":"6","key":"5630_CR39","first-page":"1382","volume":"33","author":"GD Wilbanks","year":"1973","unstructured":"Wilbanks GD: Summary of informal discussion on general aspects of cervical cancer. Cancer Res. 1973, 33 (6): 1382-1384.","journal-title":"Cancer Res"},{"key":"5630_CR40","volume-title":"Modern Epidemiology, 2nd edn","author":"K Rothman","year":"1998","unstructured":"Rothman K, Greenland S: Modern Epidemiology, 2nd edn. 1998, Boston, MA: Lippincott, Williams and Wilkins"},{"issue":"1","key":"5630_CR41","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/1471-2458-12-237","volume":"12","author":"A Horo","year":"2012","unstructured":"Horo A, Jaquet A, Ekouevi DK, Toure B, Coffie PA, Effi B, Messou E, Minga A, Moh R, Kone M: Cervical cancer screening by visual inspection in Cote d'Ivoire, operational and clinical aspects according to HIV status. BMC Public Health. 2012, 12 (1): 237-10.1186\/1471-2458-12-237.","journal-title":"BMC Public Health"},{"issue":"9","key":"5630_CR42","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.2105\/AJPH.89.9.1397","volume":"89","author":"LS Weinhardt","year":"1999","unstructured":"Weinhardt LS, Carey MP, Johnson BT, Bickham NL: Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985\u20131997. Am J Public Health. 1999, 89 (9): 1397-1405. 10.2105\/AJPH.89.9.1397.","journal-title":"Am J Public Health"},{"issue":"12","key":"5630_CR43","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1086\/599123","volume":"199","author":"DK Singh","year":"2009","unstructured":"Singh DK, Anastos K, Hoover DR, Burk RD, Shi Q, Ngendahayo L, Mutimura E, Cajigas A, Bigirimani V, Cai X, Rwamwejo J, Vuolo M, Cohen M, Castle PE: Human Papillomavirus Infection and Cervical Cytology in HIV\u2012Infected and HIV\u2012Uninfected Rwandan Women. J Infect Dis. 2009, 199 (12): 1851-1861. 10.1086\/599123.","journal-title":"J Infect Dis"},{"issue":"10","key":"5630_CR44","doi-asserted-by":"publisher","first-page":"e13525","DOI":"10.1371\/journal.pone.0013525","volume":"5","author":"K Anastos","year":"2010","unstructured":"Anastos K, Hoover DR, Burk RD, Cajigas A, Shi Q, Singh DK, Cohen MH, Mutimura E, Sturgis C, Banzhaf WC, Castle PE: Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women. PLoS One. 2010, 5 (10): e13525-10.1371\/journal.pone.0013525.","journal-title":"PLoS One"},{"issue":"10","key":"5630_CR45","doi-asserted-by":"publisher","first-page":"728","DOI":"10.7326\/0003-4819-148-10-200805200-00005","volume":"148","author":"P Patel","year":"2008","unstructured":"Patel P, Hanson DL, Sullivan PS, Novak RM, Moorman AC, Tong TC, Holmberg SD, Brooks JT: Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992\u20132003. Ann Intern Med. 2008, 148 (10): 728-736. 10.7326\/0003-4819-148-10-200805200-00005.","journal-title":"Ann Intern Med"},{"issue":"5","key":"5630_CR46","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/sj.bjc.6604923","volume":"100","author":"L Dal Maso","year":"2009","unstructured":"Dal Maso L, Polesel J, Serraino D, Lise M, Piselli P, Falcini F, Russo A, Intrieri T, Vercelli M, Zambon P: Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer. 2009, 100 (5): 840-847. 10.1038\/sj.bjc.6604923.","journal-title":"Br J Cancer"},{"key":"5630_CR47","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1039\/b923958h","volume":"6","author":"J Anderson","year":"2010","unstructured":"Anderson J, Lu E, Sanghvi H, Kibwana S, Lu A: Cervical cancer screening and prevention for HIV-infected women in the developing world. Mol Biosyst. 2010, 6: 1162-1172. 10.1039\/b923958h.","journal-title":"Mol Biosyst"},{"key":"5630_CR48","volume-title":"United States Cancer Statistics: 1999\u20132007 Incidence and Mortality Web-based Report","author":"US Cancer Statistics Working Group","year":"2010","unstructured":"US Cancer Statistics Working Group: US Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute. United States Cancer Statistics: 1999\u20132007 Incidence and Mortality Web-based Report. 2010, Atlanta GA"},{"issue":"13","key":"5630_CR49","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1097\/00002030-200309050-00015","volume":"17","author":"PB Gichangi","year":"2003","unstructured":"Gichangi PB, Bwayo J, Estambale B, De Vuyst H, Ojwang S, Rogo K, Abwao H, Temmerman M: Impact of HIV infection on invasive cervical cancer in Kenyan women. AIDS. 2003, 17 (13): 1963-1968. 10.1097\/00002030-200309050-00015.","journal-title":"AIDS"},{"issue":"3","key":"5630_CR50","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1046\/j.1525-1438.2001.01022.x","volume":"11","author":"M Moodley","year":"2001","unstructured":"Moodley M, Moodley J, Kleinschmidt I: Invasive cervical cancer and human immunodeficiency virus (HIV) infection: a South African perspective. Int J Gynecol Cancer. 2001, 11 (3): 194-197. 10.1046\/j.1525-1438.2001.01022.x.","journal-title":"Int J Gynecol Cancer"},{"issue":"12","key":"5630_CR51","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1001\/jama.293.12.1471","volume":"293","author":"TG Harris","year":"2005","unstructured":"Harris TG, Burk RD, Palefsky JM, Massad LS, Bang JY, Anastos K, Minkoff H, Hall CB, Bacon MC, Levine AM: Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results. JAMA. 2005, 293 (12): 1471-1476. 10.1001\/jama.293.12.1471.","journal-title":"JAMA"},{"issue":"2","key":"5630_CR52","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/cncr.9016","volume":"93","author":"M Cardillo","year":"2001","unstructured":"Cardillo M, Hagan R, Abadi J, Abadi MA: CD4 T-Cell count, viral load, and squamous intraepithelial lesions in women infected with the human immunodeficiency virus. Cancer Cytopathol. 2001, 93 (2): 111-114. 10.1002\/cncr.9016.","journal-title":"Cancer Cytopathol"},{"issue":"S10","key":"5630_CR53","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1002\/1097-0142(19951115)76:10+<1888::AID-CNCR2820761305>3.0.CO;2-H","volume":"76","author":"MH Schiffman","year":"2006","unstructured":"Schiffman MH, Brinton LA: The epidemiology of cervical carcinogenesis. Cancer. 2006, 76 (S10): 1888-1901.","journal-title":"Cancer"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-13-582.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2458-13-582\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-13-582","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-13-582.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:48:25Z","timestamp":1630543705000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/1471-2458-13-582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,14]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["5630"],"URL":"https:\/\/doi.org\/10.1186\/1471-2458-13-582","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,14]]},"assertion":[{"value":"12 January 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"582"}}